Abuse potential of mirogabalin in recreational polydrug users

• Main Authors: Jeanne Mendell (Author), Naama Levy-Cooperman (Author), Ed Sellers (Author), Bradley Vince (Author), Debra Kelsh (Author), James Lee (Author), Vance Warren (Author), Hamim Zahir (Author)
• Format: Book
• Published: SAGE Publishing, 2019-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Mirogabalin is a selective calcium channel α 2 δ subunit ligand being developed to treat neuropathic pain. In accordance with US Food and Drug Administration (FDA) guidance, the human abuse potential of mirogabalin (15-105 mg) was examined, relative to placebo, diazepam (15 or 30 mg), and pregabalin...